Pinsent Masons advises Yule Catto on the sale of Uquifa

01 Dec 2011 | 10:49 am | 1 min. read

International law firm Pinsent Masons has advised Yule Catto & Co plc, international producer of speciality chemicals, on the sale of its pharmaceuticals business, Uquifa to the listed Indian chemicals manufacturer Vivimed Labs for £35m.

Uquifa, which operates through Spanish and Mexican subsidiaries, is an established manufacturer of active pharmaceutical ingredients. The company has manufacturing sites in Spain and Mexico employing a total of 390 people. 

Adrian Whitfield, Chief Executive of Yule Catto said: "I am delighted to be able to announce this disposal.  Following the PolymerLatex acquisition we completed earlier this year, this marks the final step in a long process of transforming Yule Catto into a substantial highly focussed Specialty Polymer business.  We are pleased we have been able to find a good home for our Pharma business and wish the new owners and our former employees every success." 

The Pinsent Masons team advising on the sale was led by Martin Shaw, Head of Corporate, Europe, and Shiv Sibal, Senior Associate, supported by Emma Metcalfe (corporate), Michael Hunter and Jon Robinson (tax).  The team also worked closely with Yule Catto's Spanish advisers, Garrigues, and their Mexican advisers, Baker & McKenzie. Vivimed were advised by Dickinson Dees. 

Shiv Sibal, Corporate Senior Associate at Pinsent Masons LLP, commented: "The sale of Uquifa represents an important development for Yule Catto and will allow them to continue to focus on the growth of their Polymers division following their transformational acquisition of PolymerLatex earlier this year.  Having worked closely with them on the PolymerLatex acquisition, we are delighted to have supported Yule Catto again in achieving one of its strategic objectives."

Latest press releases

Show me all press releases

Pinsent Masons advises Simpson Malt Limited on £90m refinancing deal

Multinational law firm Pinsent Masons has advised Simpson Malt Limited on a £90m asset based lending (ABL) facility with PNC Business Credit.

Pinsent Masons wins 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards

Pinsent Masons was named 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards, which was held virtually on 27 November 2020.

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts